424 Capital has exited its investment in Reverba through a strategic transaction. The buyer and financial terms were not disclosed.
424 initially partnered with Reverba, previously known as Health Perspectives Group, in 2021. The investment was intended to transform its established patient-engagement services into a broader platform supporting pharmaceutical and biotechnology companies across the therapy lifecycle.
Expanding Beyond Patient Engagement
During 424 Capital’s ownership, Reverba invested in its leadership, operating infrastructure, and commercial organization.
The company also acquired Six Degrees Medical, adding medical communications and healthcare professional engagement services.
That transaction established an international presence and expanded Reverba’s involvement into earlier stages of drug development.
Reverba now helps life sciences organizations incorporate insights from patients and healthcare professionals into therapy development and commercialization. Its services are also intended to make complex diseases and treatments easier for patients to understand.
Baird served as Reverba’s exclusive financial adviser. Whiteman Osterman & Hannah provided legal counsel.
KEY QUOTES:
Reverba represents the type of business we seek to build at 424 — one with a compelling mission and a differentiated market position. We are incredibly proud of what Cheryl and the entire Reverba team accomplished during our partnership. Together, we strengthened the organization, expanded its capabilities, and built a more strategic partner to some of the world’s leading life sciences companies.
Amit Nagdev, Partner at 424 Capital
424 has been an incredibly supportive partner as we have evolved and expanded Reverba. Their team shared our conviction in the importance of our mission and invested alongside us in the people, capabilities, and infrastructure needed to serve our clients and their patients in more meaningful ways. We are proud of what we have built together and excited about Reverba’s next chapter.
Cheryl Lubbert, CEO of Reverba

